Advertisement
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Advertisement

INTRODUCTION AND OBJECTIVE:

Stone analysis is important for directing metabolic stone management of patients at risk for recurrent stones. In addition to results from 24 h urine collections, knowledge of stone composition serves as a pathway to diagnosis of underlying disorders. The objective of this study was to assess stone composition over time in patients with at least two composition analyses.

METHODS:

We retrospectively reviewed data for patients within our health system with stone composition analyses from 1997 to 2022. Patients with ≥2 analyses ≥12 months apart were identified. Stones were collected through spontaneous passage or procedures (shock wave lithotripsy, ureteroscopy, or percutaneous nephrolithotomy). Patients’ predominant stone compositions were defined as the component ≥60% and were otherwise considered mixed. Stones that were 100% organic material were excluded from analysis. Univariate analyses (chi-square, T test) were used to compare patients’ stone analyses.

RESULTS:

We reviewed 4131 stone analyses and identified 338 patients with 2 or more analyses and 76 patients who had three or more analyses. Patients were 41% female and averaged 51±14 years (min-max 18-84 years) at the time of their first stone composition. Eighty-nine (26.3%) patients had a change in their predominant stone component from the first to second stone; 26 (34.2%) had a change from the first to third stone. The mean time between the first and second stone analyses was 54 months (range 12-188, median 44 months); time between the second and third stone analyses was 76 months (range 14-258, median 61 months). A small number of patients, 3.2% of all calcium oxalate stone formers, changed from predominantly calcium oxalate in the first stone analysis to calcium phosphate in the second. This was not different (p=0.84, Fisher’s exact test) than the number whose stones changed from calcium phosphate in the first stone analysis to calcium oxalate in the second (3.8%) (Figure 1).

CONCLUSIONS:

Patients’ stone composition demonstrated variability in repetitive analyses. Repeating stone analyses may be an important component of long term medical stone management for individual patients.

Download PPT

Source of Funding:

None